Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Dexamethasone (base) 3.3mg/1ml solution for injection ampoules (hameln pharma Ltd) |
| BNF code | 0603020AAAAABAB |
| Virtual Medicinal Product | Dexamethasone (base) 3.3mg/1ml solution for injection ampoules |
| Name | Dexamethasone (base) 3.3mg/1ml solution for injection ampoules |
| Abbreviated name | Dexamethasone (base) 3.3mg/1ml inj ampoules |
| Date of name applicability | 31 May 2018 |
| Previous name | Dexamethasone 3.3mg/1ml solution for injection ampoules |
| Supplier | hameln pharma Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Licensed Route | |
| Licenced route | Intralesional |
| Licensed Route | |
| Licenced route | Intravenous |
| Licensed Route | |
| Licenced route | Intramuscular |
| Licensed Route | |
| Licenced route | Intrabursal |
| Licensed Route | |
| Licenced route | Intraarticular |
| Actual Medicinal Product Packs | |
| Dexamethasone (base) 3.3mg/1ml solution for injection ampoules (hameln pharma Ltd) 10 ampoule 2 x 5 x 1ml ampoules | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.